Becton Dickinson and Company Asset Resilience Ratio
Becton Dickinson and Company asset resilience ratio. Becton Dickinson and Company (BDX) has an Asset Resilience Ratio of 0.00% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Becton Dickinson and Company debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Becton Dickinson and Company (1999–2025)
Asset resilience ratio of Becton Dickinson and Company from 1999 to 2025. This chart shows how Becton Dickinson and Company's Asset Resilience Ratio has changed over time. See BDX FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Becton Dickinson and Company's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see BDX current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $1.00 Million | 0.0% |
| Total Liquid Assets | $1.00 Million | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Becton Dickinson and Company maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Becton Dickinson and Company Industry Peers by Asset Resilience Ratio
Compare Becton Dickinson and Company's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Mingyue Optical Lens Co.Ltd.
SHE:301101 |
Medical Instruments & Supplies | 47.21% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
Mercator Medical S.A.
WAR:MRC |
Medical Instruments & Supplies | 7.15% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
|
Crossject
PA:ALCJ |
Medical Instruments & Supplies | 1.31% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
Becton Dickinson and Company Asset Resilience Ratio by Year (1999–2025)
Becton Dickinson and Company asset resilience ratio by year from 1999 to 2025. The table below shows the annual Asset Resilience Ratio data for Becton Dickinson and Company.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-09-30 | 1.17% | $649.00 Million | $55.33 Billion | -2.60pp |
| 2024-09-30 | 3.77% | $2.16 Billion | $57.29 Billion | +1.08pp |
| 2023-09-30 | 2.70% | $1.42 Billion | $52.78 Billion | +0.78pp |
| 2022-09-30 | 1.92% | $1.01 Billion | $52.93 Billion | -2.34pp |
| 2021-09-30 | 4.26% | $2.29 Billion | $53.88 Billion | -1.01pp |
| 2020-09-30 | 5.27% | $2.85 Billion | $54.01 Billion | +4.18pp |
| 2019-09-30 | 1.09% | $566.00 Million | $51.84 Billion | -1.05pp |
| 2018-09-30 | 2.15% | $1.16 Billion | $53.90 Billion | -35.53pp |
| 2017-09-30 | 37.67% | $14.22 Billion | $37.73 Billion | +30.22pp |
| 2016-09-30 | 7.45% | $1.91 Billion | $25.59 Billion | +7.10pp |
| 2015-09-30 | 0.35% | $95.00 Million | $26.82 Billion | -6.75pp |
| 2014-09-30 | 7.10% | $884.00 Million | $12.45 Billion | +1.19pp |
| 2013-09-30 | 5.91% | $718.00 Million | $12.15 Billion | +1.42pp |
| 2012-09-30 | 4.49% | $509.57 Million | $11.36 Billion | +0.77pp |
| 2011-09-30 | 3.72% | $388.03 Million | $10.43 Billion | -1.75pp |
| 2010-09-30 | 5.47% | $528.21 Million | $9.65 Billion | -0.45pp |
| 2009-09-30 | 5.93% | $551.56 Million | $9.30 Billion | +3.40pp |
| 2008-09-30 | 2.53% | $199.94 Million | $7.91 Billion | +0.37pp |
| 2007-09-30 | 2.16% | $158.04 Million | $7.33 Billion | +0.60pp |
| 2006-09-30 | 1.56% | $106.39 Million | $6.82 Billion | +0.13pp |
| 2005-09-30 | 1.43% | $86.81 Million | $6.07 Billion | +0.87pp |
| 2004-09-30 | 0.56% | $32.12 Million | $5.75 Billion | +0.52pp |
| 2002-09-30 | 0.04% | $1.85 Million | $5.04 Billion | -0.06pp |
| 2001-09-30 | 0.10% | $4.57 Million | $4.80 Billion | -0.03pp |
| 2000-09-30 | 0.12% | $5.56 Million | $4.51 Billion | +0.02pp |
| 1999-09-30 | 0.11% | $4.70 Million | $4.44 Billion | -- |
About Becton Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segme… Read more